Cleared Traditional

K103165 - BLOOD SAMPLING SET

K103165 is an FDA 510(k) clearance for BLOOD SAMPLING SET, manufactured by Acacia, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K103165 · Acacia, Inc. · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2010
Decision
14d
Days
Class 2
Risk

K103165 is an FDA 510(k) clearance for the BLOOD SAMPLING SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Acacia, Inc. (Brea, US). The FDA issued a Cleared decision on November 10, 2010 after a review of 14 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K103165

510(k) Number K103165 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 2010
Decision Date November 10, 2010
Days to Decision 14 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
115d faster than avg
Panel avg: 129d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 1062
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K103165.
INFUSION SETS
K103344 · Hospira, Inc. · Dec 2010
K-SHIELD PORT ACCESS INFUSION SET WITH HIGH PRESSURE TUBING
K100720 · Kawasumi Laboratories, Inc. · Nov 2010
D. HEART MEDICAL INTRAVASCULAR ADMINISTRATION SET, SAFETY ACCES DEVICE AND ACCESSORIES
K101368 · Dragon Heart Medical, Inc. · Nov 2010
MED-RX TRANSFER SET, MODELS 10-1227TS, 10-1300TS, 10-1305TS AND 10-1306TS
K102073 · Benlan, Inc. · Nov 2010
K-SHIELD SMALL VEIN INFUSION / WINGED COLLECTION SET W/ ANTI NEEDLE STICK PROTECTOR (AND MULTISAMPLE LUER ADAPTER)
K102890 · Kawasumi Laboratories America, Inc. · Oct 2010
AMSINO I.V. ADMINISTRATION AND EXTENSION SETS
K101958 · Amsino International, Inc. · Sep 2010
K103165 · BLOOD SAMPLING SET
Download PDF FDA Summary Acacia, Inc.